A novel mechanism-based pharmacokinetic–pharmacodynamic (PKPD) model describing ceftazidime/avibactam efficacy against β-lactamase-producing Gram-negative bacteria
Anders Kristoffersson(Uppsala University), Elisabet I. Nielsen(Uppsala University), Claudia Zampaloni(Roche (Switzerland)), Caterina Bissantz(Roche (Switzerland)), Isabelle Walter(Roche (Switzerland)), Andreas Haldimann(Purdue University West Lafayette), Tianlai Shi(Roche (Switzerland)), Rusudan Okujava(Roche (Switzerland))
Cited by 18
Related Papers
A Medicinal Chemist’s Guide to Molecular Interactions
|Journal of Medicinal Chemistry|2010|1.7k
Conditional-Replication, Integration, Excision, and Retrieval Plasmid-Host Systems for Gene Structure-Function Studies of Bacteria
|Journal of Bacteriology|2001|599
Conditionally Replicative and Conjugative Plasmids CarryinglacZα for Cloning, Mutagenesis, and Allele Replacement in Bacteria
|Plasmid|1996|437
The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections
|Intensive Care Medicine|2017|149